alexa
Reach Us +1-217-403-9671
Editor - Rabih Halwani | King Saud University | 18734
ISSN: 2472-1018

Journal of Lung Diseases & Treatment
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Rabih Halwani

Rabih Halwani
Rabih Halwani
Scientific Director.
Prince Naif Center for Immunology Research (PNCIR)
Asthma Research Chair; College of Medicine
King Saud University
Riyadh
Saudi Arabia

Biography

Dr. Halwani obtained a PhD in virology and immunology from McGill University, Montreal, Canada where he was studying HIV viral assembly and viral cellular interaction. He then did a postdoctoral fellowship at the CHUM research center with Dr. Rafick Sekaly where he was trained as an immunologist studying qualitative and quantitative immune correlates of protection against viral infection especially HIV. Dr. Halwani developed extensive expertise in both molecular biology and cellular immunology including the development of assays to measure T cell survival and persistence in non-humans primates. He was also among the first to successfully implement the use of phosFLow technology, which allows measuring phosphorylated molecules by flow cytometry to monitor T cell activation ex vivo, on samples from non-human primates

Research Interest

Dr. Halwani is interested in studying the molecular mechanisms involved in lung tissue remodeling during Asthma. Airway tissue remodeling is the key physiological feature underlying asthma pathogenesis. It refers to the modification of the normal composition and structural organization of lung tissue which usually occurs in response to inflammatory responses associated with asthma and COPD. This involves a wide pattern of pathophysiological mechanisms. Dr. Halwani investigates the molecular mechanisms involved in these processes from several angles in the aim to discover novel drug targets that would help control asthma pathogenesis.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top